Patents by Inventor James Fiordeliso

James Fiordeliso has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100270916
    Abstract: Novel organic compounds comprising ligands with deuterium substitution are provided. In particular, the compound is an iridium complex comprising methyl-d3 substituted ligands. The compounds may be used in organic light emitting devices to provide devices having improved color, efficiency and lifetime.
    Type: Application
    Filed: April 27, 2010
    Publication date: October 28, 2010
    Applicant: Universal Display Corporation
    Inventors: Chuanjun XIA, James FIORDELISO, Raymond KWONG
  • Publication number: 20090108737
    Abstract: Phosphorescent materials and devices with improved device manufacturing, fabrication, stability, efficiency, and/or color.
    Type: Application
    Filed: March 7, 2008
    Publication date: April 30, 2009
    Inventors: Raymond KWONG, Chuanjun Xia, Jason Brooks, Bert Alleyne, Bin Ma, James Fiordeliso, Yonggang Wu
  • Publication number: 20080119500
    Abstract: The present invention is directed to novel heteroatom containing tetracyclic derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders mediated by one or more estrogen receptors. The compounds of the invention are useful in the treatment of disorders associated with the depletion of estrogen such as hot flashes, vaginal dryness, osteopenia and osteoporosis; hormone sensitive cancers and hyperplasia of the breast, endometrium, cervix and prostate; endometriosis, uterine fibroids, osteoarthritis and as contraceptive agents, alone or in combination with a progestogen or progestogen antagonist.
    Type: Application
    Filed: February 1, 2008
    Publication date: May 22, 2008
    Inventors: Weiqin Jiang, James Fiordeliso, Zhihua Sui
  • Publication number: 20080070970
    Abstract: The present invention is directed to novel indole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    Type: Application
    Filed: September 20, 2007
    Publication date: March 20, 2008
    Inventors: James Lanter, Zhihua Sui, James Fiordeliso, Weiqin Jiang, Xuqing Zhang
  • Publication number: 20070232570
    Abstract: The present invention is directed to novel 11-phosphorous steroid derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by a progesterone or glucocorticoid receptor.
    Type: Application
    Filed: February 16, 2007
    Publication date: October 4, 2007
    Inventors: James Fiordeliso, Weiqin Jiang, Zhihua Sui
  • Publication number: 20070135511
    Abstract: The present invention is directed to novel indole derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by agonists and antagonists of the progesterone receptor. The clinical uses of these compounds are related to contraception, the treatment and/or prevention of secondary amenorrhea, dysfunctional bleeding, uterine leiomyomata, endometriosis; polycystic ovary syndrome, carcinomas and adenocarcinomas of the endometrium, ovary, breast, colon, prostate, or minication of side effects of cyclid menstrual bleeding. Additional uses of the invention include stimulation of food intake.
    Type: Application
    Filed: January 16, 2007
    Publication date: June 14, 2007
    Inventors: Weiqin Jiang, James Fiordeliso, Zhihua Sui
  • Publication number: 20060111427
    Abstract: The present invention is directed to novel indole derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by agonists and antagonists of the progesterone receptor. The clinical uses of these compounds are related to contraception, the treatment and/or prevention of secondary amenorrhea, dysfunctional bleeding, uterine leiomyomata, endometriosis; polycystic ovary syndrome, carcinomas and adenocarcinomas of the endometrium, ovary, breast, colon, prostate, or minication of side effects of cyclid menstrual bleeding. Additional uses of the invention include stimulation of food intake.
    Type: Application
    Filed: October 21, 2005
    Publication date: May 25, 2006
    Inventors: Weiqin Jiang, James Fiordeliso, Zhihua Sui
  • Publication number: 20060106047
    Abstract: The present invention is directed to novel trisubstituted thiophene derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by agonists and antagonists of the progesterone receptor. The clinical usage of these compounds are related to hormonal contraception, the treatment and/or prevention of secondary dysmenorrhea, amenorrhea, dysfunctional uterine bleeding, uterine leiomyomata, endometriosis; polycystic ovary syndrome, carcinomas and adenocarcinomas of the endometrium, ovary, breast, colon or prostate. Additional uses of the invention include stimulation of food intake.
    Type: Application
    Filed: October 21, 2005
    Publication date: May 18, 2006
    Inventors: Weiqin Jiang, James Fiordeliso, Zhihua Sui
  • Publication number: 20060040917
    Abstract: The present invention is directed to novel benzoxazepine derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and diseases mediated by an estrogen receptor.
    Type: Application
    Filed: July 28, 2005
    Publication date: February 23, 2006
    Inventors: James Lanter, Zhihua Sui, James Fiordeliso
  • Publication number: 20050250740
    Abstract: The present invention is directed to novel indole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    Type: Application
    Filed: April 1, 2005
    Publication date: November 10, 2005
    Inventors: James Lanter, Zhihua Sui, James Fiordeliso, Weiqin Jiang, Xuqing Zhang
  • Publication number: 20050250741
    Abstract: The present invention is directed to novel indole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    Type: Application
    Filed: April 1, 2005
    Publication date: November 10, 2005
    Inventors: James Lanter, Zhihua Sui, James Fiordeliso, Weiqin Jiang, Xuqing Zhang
  • Publication number: 20050245485
    Abstract: The present invention is directed to novel indole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    Type: Application
    Filed: April 1, 2005
    Publication date: November 3, 2005
    Inventors: James Lanter, Zhihua Sui, James Fiordeliso, Weiqin Jiang, Xuqing Zhang
  • Publication number: 20050107372
    Abstract: The present invention is directed to novel 2-(quinolonyl)-fused heterocyclyl derivatives of the general formula (I) wherein R1, R2, R3, R3a, R4, R5, R6 and R7 are as herein defined, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    Type: Application
    Filed: September 29, 2004
    Publication date: May 19, 2005
    Inventors: James Lanter, Zhihua Sui, James Fiordeliso